La société biopharmaceutique danoise Tetra Pharm Technologies est fière d’annoncer le lancement de son médicament analgésique sur ordonnance, XATEPA®, au Royaume-Uni. COPENHAGUE, Danemark, 19 mars 2024 /PRNewswire/ — À la suite du lancement réussi de XATEPA® en Allemagne l’an dernier, le…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.